Literature DB >> 20938470

Treating periodontal disease may improve metabolic control in diabetics.

Jean-Noel Vergnes1.   

Abstract

DATA SOURCES: The Cochrane Oral Health Group's Trials Register, The Cochrane Central Register of Controlled Trials (CENTRAL), Medline, EMBASE, CINAHL, ZETOC, ISIWeb of Knowledge and LILACS databases were searched together with hand searches of the journals Annals of Periodontology (1996 to 2003) and Periodontology 2000 (1993 to 2003).There were no language restrictions. STUDY SELECTION: This review included randomised controlled trials of people with type 1 or 2 diabetes mellitus (DM) with a diagnosis of periodontitis. Suitable interventions included mechanical periodontal therapy with or without adjunctives and oral hygiene education. DATA EXTRACTION AND SYNTHESIS: The titles and abstracts of all identified papers were examined by two review authors' independently. All included trials were assessed for risk of bias. Data were collated in evidence tables, grouped according to research design and assessed for possible meta-analysis on the basis of homogeneity of main characteristics.
RESULTS: Seven studies were included and three studies had results pooled into a meta-analysis. The effect for the mean percentage difference in HbA1c for scaling/root planing and oral hygiene (+/- antibiotic therapy) versus no treatment/usual treatment after 3/4 months was -0.40% (95% confidence interval (CI) fixed effect -0.78% to -0.01%), representing a statistically significant reduction in HbA1c (P = 0.04) for scaling/root planing. One study was assessed as being at low risk of bias with the other two at moderate to high risk of bias. A subgroup analysis examined studies without adjunctive antibiotics -0.80% (one study: 95% CI -1.73% to 0.13%; P = 0.09), with adjunctive antibiotics in the test group -0.36% (one study: 95% CI -0.83% to 0.11%; P = 0.14), and with antibiotics in both test and control groups after 3/4 months -0.15% (one study: 95% CI -1.04% to 0.74%; P = 0.74).
CONCLUSIONS: There is some evidence of improvement in metabolic control in people with diabetes, after treating periodontal disease. There are few studies available and individually these lacked the power to detect a significant effect. Most of the participants in the study had poorly controlled type 2 DM and there was little data from randomised trials on the effects on people with type 1 DM. Improving periodontal health is an important objective in itself. However, in order to understand the potential of this treatment to improve glycaemic control among people with diabetes, larger, carefully conducted and reported studies are needed.

Entities:  

Year:  2010        PMID: 20938470     DOI: 10.1038/sj.ebd.6400734

Source DB:  PubMed          Journal:  Evid Based Dent        ISSN: 1462-0049


  5 in total

1.  Review finds periodontal treatment has short term benefits for diabetics.

Authors:  Jean-Noel Vergnes
Journal:  Evid Based Dent       Date:  2015-09

Review 2.  Oral microbiota-induced periodontitis: a new risk factor of metabolic diseases.

Authors:  Matthieu Minty; Thibault Canceil; Matteo Serino; Remy Burcelin; François Tercé; Vincent Blasco-Baque
Journal:  Rev Endocr Metab Disord       Date:  2019-12       Impact factor: 6.514

Review 3.  Management of diabolical diabetes mellitus and periodontitis nexus: Are we doing enough?

Authors:  Abhijit N Gurav
Journal:  World J Diabetes       Date:  2016-02-25

4.  Psychologically informed oral health interventions in pregnancy and type 2 diabetes: a scoping review protocol.

Authors:  Camilla Böhme Kristensen; Mark Ide; Angus Forbes; Koula Asimakopoulou
Journal:  BMJ Open       Date:  2022-09-19       Impact factor: 3.006

5.  Periodontitis induced by Porphyromonas gingivalis drives periodontal microbiota dysbiosis and insulin resistance via an impaired adaptive immune response.

Authors:  Vincent Blasco-Baque; Lucile Garidou; Céline Pomié; Quentin Escoula; Pascale Loubieres; Sandrine Le Gall-David; Mathieu Lemaitre; Simon Nicolas; Pascale Klopp; Aurélie Waget; Vincent Azalbert; André Colom; Martine Bonnaure-Mallet; Philippe Kemoun; Matteo Serino; Rémy Burcelin
Journal:  Gut       Date:  2016-02-02       Impact factor: 23.059

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.